Standout Papers

Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria 2021 2026 2022 2024224
  1. Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria (2021)
    Peter Hillmen, Jeff Szer et al. New England Journal of Medicine

Immediate Impact

40 standout
Sub-graph 1 of 16

Citing Papers

Synergistic improvements of properties of cellulose acetate based curcumin@TiO2 nanofibers via triaxial electrospinning
2025 Standout
Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics
2025 Standout
2 intermediate papers

Works of Lisa Tan being referenced

Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
2021 Standout
C3 inhibition with pegcetacoplan in subjects with paroxysmal nocturnal hemoglobinuria treated with eculizumab
2020
and 1 more

Author Peers

Author Last Decade Papers Cites
Lisa Tan 344 127 172 170 11 402
Carolina González-Rubio 313 80 124 172 14 421
Federica Banterla 314 71 217 144 7 426
Raymond Camilleri 317 163 174 221 13 429
Jing L. Marantz 156 49 64 61 16 340
Jeffrey Gryn 157 93 61 227 14 386
Laleh Khodadadi 256 38 23 47 11 407
Sandra Christoph 240 21 14 157 17 424
Adam Davison 270 21 18 87 12 427
Varsha D. K. D. Sewgobind 230 27 25 34 11 362
Konstantia-Maria Chavele 261 32 30 23 7 393

All Works

Loading papers...

Rankless by CCL
2026